Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database - PubMed (original) (raw)

Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome.

Berardi G, Cucchetti A, Sposito C, Ratti F, Nebbia M, D'Souza DM, Pascual F, Dogeas E, Tohme S, Vitale A, D'Amico FE, Alessandris R, Panetta V, Simonelli I, Colasanti M, Russolillo N, Moro A, Fiorentini G, Serenari M, Rotellar F, Zimitti G, Famularo S, Ivanics T, Donando FG, Hoffman D, Onkendi E, Essaji Y, Giuliani T, Lopez Ben S, Caula C, Rompianesi G, Chopra A, Abu Hilal M, Sapisochin G, Torzilli G, Corvera C, Alseidi A, Helton S, Troisi RI, Simo K, Conrad C, Cescon M, Cleary S, Kwon DCH, Ferrero A, Ettorre GM, Cillo U, Geller D, Cherqui D, Serrano PE, Ferrone C, Aldrighetti L, Kingham TP, Mazzaferro V. Berardi G, et al. JHEP Rep. 2024 Apr 24;6(7):101075. doi: 10.1016/j.jhepr.2024.101075. eCollection 2024 Jul. JHEP Rep. 2024. PMID: 38961853 Free PMC article.